These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17080408)

  • 21. Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response.
    Hansen B; Sokolovska A; HogenEsch H; Hem SL
    Vaccine; 2007 Sep; 25(36):6618-24. PubMed ID: 17681647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure and properties of aluminum-containing adjuvants.
    Hem SL; White JL
    Pharm Biotechnol; 1995; 6():249-76. PubMed ID: 7551220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural perturbation of diphtheria toxoid upon adsorption to aluminium hydroxide adjuvant.
    Régnier M; Metz B; Tilstra W; Hendriksen C; Jiskoot W; Norde W; Kersten G
    Vaccine; 2012 Nov; 30(48):6783-8. PubMed ID: 23000120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and immunogenicity of a potential multivalent type III secretion system-based protein vaccine.
    Markham AP; Barrett BS; Esfandiary R; Picking WL; Picking WD; Joshi SB; Middaugh CR
    J Pharm Sci; 2010 Nov; 99(11):4497-509. PubMed ID: 20845449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of adsorption of three recombinant Streptococcus pneumoniae (Sp) vaccine antigens by an aluminum adjuvant.
    Levesque PM; de Alwis U
    Hum Vaccin; 2005; 1(2):70-3. PubMed ID: 17038824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An intrinsic fluorescence method for the determination of protein concentration in vaccines containing aluminum salt adjuvants.
    Nouchikian L; Roque C; Song JY; Rahman N; Ausar SF
    Vaccine; 2018 Sep; 36(38):5738-5746. PubMed ID: 30107994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparable quality attributes of hepatitis E vaccine antigen with and without adjuvant adsorption-dissolution treatment.
    Zhang Y; Li M; Yang F; Li Y; Zheng Z; Zhang X; Lin Q; Wang Y; Li S; Xia N; Zhang J; Zhao Q
    Hum Vaccin Immunother; 2015; 11(5):1129-39. PubMed ID: 26018442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability.
    Clapp T; Siebert P; Chen D; Jones Braun L
    J Pharm Sci; 2011 Feb; 100(2):388-401. PubMed ID: 20740674
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Khatun R; Hunter HN; Sheng Y; Carpick BW; Kirkitadze MD
    J Pharm Biomed Anal; 2018 Sep; 159():166-172. PubMed ID: 29990882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens.
    Agarwal S; Hickey JM; McAdams D; White JA; Sitrin R; Khandke L; Cryz S; Joshi SB; Volkin DB
    J Pharm Sci; 2020 Jan; 109(1):476-487. PubMed ID: 31589875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accelerating Vaccine Formulation Development Using Design of Experiment Stability Studies.
    Ahl PL; Mensch C; Hu B; Pixley H; Zhang L; Dieter L; Russell R; Smith WJ; Przysiecki C; Kosinski M; Blue JT
    J Pharm Sci; 2016 Oct; 105(10):3046-3056. PubMed ID: 27522919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of particle size and antigen binding on effectiveness of aluminum salt adjuvants in a model lysozyme vaccine.
    Clausi A; Cummiskey J; Merkley S; Carpenter JF; Braun LJ; Randolph TW
    J Pharm Sci; 2008 Dec; 97(12):5252-62. PubMed ID: 18398901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of protein adsorption on the surface charge characteristics of aluminium-containing adjuvants.
    al-Shakhshir R; Regnier F; White JL; Hem SL
    Vaccine; 1994 Apr; 12(5):472-4. PubMed ID: 8023556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of aluminium-containing adjuvants during aging at room temperature.
    Burrell LS; White JL; Hem SL
    Vaccine; 2000 Apr; 18(21):2188-92. PubMed ID: 10717337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NaCl strongly modifies the physicochemical properties of aluminum hydroxide vaccine adjuvants.
    Art JF; Vander Straeten A; Dupont-Gillain CC
    Int J Pharm; 2017 Jan; 517(1-2):226-233. PubMed ID: 27956190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-assembled aluminum oxyhydroxide nanorices with superior suspension stability for vaccine adjuvant.
    Bi S; Li M; Liang Z; Li G; Yu G; Zhang J; Chen C; Yang C; Xue C; Zuo YY; Sun B
    J Colloid Interface Sci; 2022 Dec; 627():238-246. PubMed ID: 35849857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation.
    Hem SL; Hogenesch H
    Expert Rev Vaccines; 2007 Oct; 6(5):685-98. PubMed ID: 17931150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atomic-Scale Description of Interfaces between Antigen and Aluminum-Based Adjuvants Used in Vaccines by Dynamic Nuclear Polarization (DNP) Enhanced NMR Spectroscopy.
    Viger-Gravel J; Paruzzo FM; Cazaux C; Jabbour R; Leleu A; Canini F; Florian P; Ronzon F; Gajan D; Lesage A
    Chemistry; 2020 Jul; 26(41):8976-8982. PubMed ID: 32428253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation development of a plant-derived H1N1 influenza vaccine containing purified recombinant hemagglutinin antigen.
    Iyer V; Liyanage MR; Shoji Y; Chichester JA; Jones RM; Yusibov V; Joshi SB; Middaugh CR
    Hum Vaccin Immunother; 2012 Apr; 8(4):453-64. PubMed ID: 22370514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response.
    Noe SM; Green MA; HogenEsch H; Hem SL
    Vaccine; 2010 Apr; 28(20):3588-94. PubMed ID: 20211692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.